Search


Important Information for the Hemophilia Community Regarding Triad Group’s Alcohol Prep Products and Bayer’s BayCuff™ and First Aid Kit… learn more »

Kogenate FS Logo - antihemophilic factor (recombinant) for the treatment of Hemophilia A

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to AHF. Continue Reading Below »

Monitor your patients with just one click

EZ-LOG Web Diary…The interactive link for healthcare providers and patients with hemophilia A

Monitor your hemophilia A patients' therapy through EZ-LOG Web Diary, a reliable way for you to obtain interim patient reports between visits and maintain records to be included in your patients' charts. The questions EZ-LOG Web Diary can help you answer include:

  • How are my patients doing between visits?
  • How often are they infusing?
  • Are my dosing instructions being followed correctly?

Features of EZ-LOG Web Diary include:

  • Safe storage of your patients' infusion histories so that they can't lose or misplace them
  • Review infusion entries and see specific details for every entry recorded during that period, including date and time, patient, reason for infusion, product, and dose
  • Helpful treatment reports to track your patients' therapy and ongoing hemophilia A management
  • Tracking to identify lot number of product
  • E-mail notifications to help patients maintain adequate factor inventory
  • 1-to-1 messaging between patients, hemophilia treatment centers, physicians, and home healthcare providers via their computer
  • Optional text messaging feature that allows patients to stay informed about important information regarding therapy via their mobile phone
  • Secure, password-protected information management and encrypted data transmission
  • HIPAA-compliant data storage and privacy protocols

EZ-LOG Web Diary is a free, effective way to help maintain contact with your patients between visits, regardless of the product you prescribe.

For more information on EZ-LOG Web Diary, contact your Bayer Account Executive.

IMPORTANT
Although Bayer HealthCare makes every reasonable effort to protect your data from interception, misuse, or alteration by third parties, you should be aware that there is always some risk involved in transmitting information over the Internet and that thieves could find a way to thwart our security systems.

EZ-LOG Web Diary is not intended to replace your routine communication with patients.

EZ-LOG Web Diary support is available Monday through Friday between 8:00 a.m. and 8:00 p.m. EST/EDT via phone at 800-732-4188, ext 27, and by e-mail anytime at support@aheh.com.

INDICATIONS & USAGE

Kogenate® FS, antihemophilic factor (recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

IMPORTANT SAFETY INFORMATION

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Kogenate® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For important risk and use information, please see the full prescribing information.

Prescribing Information | Privacy Policy | Terms of Use | Sitemap

© 2010 Bayer HealthCare Pharmaceuticals Inc. All rights reserved.
BAYER, the Bayer Cross, and KOGENATE are registered trademarks of Bayer.
BIO-SET is a trademark of Biodome SAS.

Bayer HealthCare Pharmaceuticals

Kogenate FS Antihemophilic Factor (Recombinant) with BIO-SET Needleless Reconstitution System